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Abstract 
Acute myocardial infarction is a rare event in a patient with a left ventricular 
assist device (LVAD). We present a case of ST-segment elevation myocardial 
infarction in a LVAD patient. 
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A 53 year-old male with a HeartMate II (Thoratec Corporation, Pleasanton, CA) 
left ventricular assist device (LVAD) presented to an outside emergency 
department with acute onset of chest pain.  LVAD placement occurred 5 months 
prior to patient’s presentation due to end-stage ischemic cardiomyopathy.  The 
patient’s history was significant for refractory gastrointestinal bleeding while on 
LVAD support which resulted in complete cessation of all anticoagulation 
including aspirin.  ECG demonstrated significant ST elevation in the anterior 
leads.  The patient was given aspirin and started on intravenous heparin and 
transferred to our institution for urgent left heart catheterization.  Catheterization 
showed 100% thrombotic occlusion of the mid left anterior descending artery 
(Figure 1).  Aspiration thrombectomy and percutaneous transluminal coronary 
angioplasty were performed with successful result and minimal residual disease 
(Figure 2).  Mild to moderate disease was found elsewhere consistent with his 
history of known ischemic heart failure.  The patient was loaded with 600 mg of 
clopidogrel.  Chest pain completely resolved.  
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Fig 1. Total left anterior descending artery occlusion on coronary 
angiogram. Video at: https://vimeo.com/130852738  
 
 
Fig 2. Restoration of flow in left anterior descending artery following 
successful thrombectomy and angioplasty. 
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However, the day following the procedure, the patient developed acute onset of 
right facial droop, expressive aphasia, and right-sided weakness.  Emergent 
head CT with angiography showed a thrombus within the left middle cerebral 
artery (M1 segment).  Urgent cerebral angiography was performed and the 
patient underwent successful mechanical thrombectomy of the left middle 
cerebral artery with restoration of 85% of the left middle cerebral circulation.  The 
patient’s neurological status dramatically improved.   
 Both of these events appeared to be embolic in nature, possibly 
contributed by the patient’s lack of anticoagulation.  Upon admission, lactate 
dehydrogenase (LDH) was elevated at 466 U/L compared to 232 U/L 1 month 
prior to admission.  Free hemoglobin was elevated as well at 45 mg/dL.  
Transthoracic echocardiogram showed no visible thrombus in left ventricular 
cavity and Doppler velocities through inflow cannula were normal.  Parameters 
were normal on LVAD interrogation and no power spikes were noted.   
Given that he had no active signs of gastrointestinal bleeding, the patient 
was started on intravenous heparin and warfarin and aspirin were also initiated.  
The patient did well initially with continued improvement in his neurological 
deficits.  However eight days after admission to the hospital, he developed new 
aphasia and hemiparesis once again.  Urgent head CT showed the new 
development of an intraparenchymal hematoma centered in the temporal lobe 
with mild mass effect.  The patient was not believed to be a candidate for 
neurosurgical intervention.  As a result, anticoagulation was stopped, including 
clopidogrel.  Despite the new neurological insult, over the next several days the 
patient once again was improving from a neurological standpoint.  However, 16 
days following hospital admission, his mental status acutely deteriorated and he 
became unresponsive.  Head CT showed a new acute infarction in the right 
middle cerebral artery territory.  Given his general poor prognosis, the family 
elected to proceed with comfort measures and he died on hospitalization day 
#20.  The family declined autopsy, and the LVAD was not sent to the 
manufacturer. 
Acute myocardial infarction following LVAD implantation is a rare 
phenomenon.  The latest annual INTERMACS report showed that myocardial 
infraction occurred in the first 12 months after LVAD implant at a rate of 0.08 
events per 100 patient-months.1 Compared to other adverse events such as 
bleeding, right heart failure, arrhythmias, and infection, myocardial infarction is 
far less common.  ST-segment elevation myocardial infarction has been reported 
in an LVAD patient soon after implant due to thrombotic occlusion of the left 
coronary cusp.2 In the present case, we hypothesize that our patient’s myocardial 
infarction and stroke were likely embolic events from a thrombus in the blood 
pump pathway.  The exact location of the thrombus was not certain.  LDH and 
free hemoglobin were both elevated, but other LVAD parameters including power 
were normal.  However, it is well known that LDH can often be the only sign of 
impending LVAD thrombosis.3 Lack of anticoagulation due to refractory 
gastrointestinal bleeding likely was the major factor contributing to thrombus 
formation.  Recent data suggests that rates of LVAD thrombosis are increasing 
and clinicians should be aware that acute myocardial infarction may be evidence 
of this complication.4 We hope that this case report adds awareness to this 
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potential complication which may become more common as patients are living 
longer with continuous-flow LVADs.   
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